- 英文名称
- TMC647055
- 分子式
- C32H38N4O6S
- 分子量
- 606.73
- 中文别名
- Tmc-647055; TMC 647055; 2,19-methano-3,7:4,1-dimetheno-1H,11H-14,10,2,9,11,17-benzoxathiatetraazacyclodocosine-8,18(9H,15H)-dione 10,10-dioxide; 28-Cyclohexyl-22-methoxy-10,16-dimethyl-13-oxa-9-thia-1,8,10,16-tetraazapentacyclo[16.8.1.1.1.0]nonacosa-2(29),3,5,18,20,22,24,26(28)-octaene-7,17-dione 9,9-dioxide; 10,6-(Methanoiminothioiminoethanooxyethanoiminomethano)-7H-indolo[2,1-a][2]benzazepine-14,24-dione, 13-cyclohexyl-3-methoxy-17,23-dimethyl-, 16,16-dioxide; 2,19-Methano-3,7:4,1-dimetheno-1H,11H-14,10,2,9,11,17-benzoxathiatetraazacyclodocosine-8,18(9H,15H)-dione, 27-cyclohexyl-12,13,16,17-tetrahydro-22-methoxy-11,17-dimethyl-, 10,10-dioxide; 28-cyclohexyl-22-methoxy-10,16-dimethyl-13-oxa-9lambda6-thia-1,8,10,16-tetraazapentacyclo(16.8.1.1^(2,6).1^(3,26).0^(20,25))nonacosa-2(29),3,5,18,20,22,24,26(28)-octaene-7,9,9,17-tetrone; 28-cyclohexyl-22-methoxy-10,16-dimethyl-13-oxa-9lambda6-thia-1,8,10,16-tetraazapentacyclo[16.8.1.1^{2,6}.1^{3,26}.0^{20,25}]nonacosa-2(29),3,5,18,20,22,24,26(28)-octaene-7,9,9,17-tetrone; 28-cyclohexyl-22-methoxy-10,16-dimethyl-9,9-dioxo-13-oxa-9lambda6-thia-1,8,10,16-tetrazapentacyclo[16.8.1.12,6.13,26.020,25]nonacosa-2,4,6(29),18,20(25),21,23,26(28)-octaene-7,17-dione; 113-cyclohexyl-13-methoxy-5,11-dimethyl-17H-8-oxa-4-thia-3,5,11-triaza-1(10,6)-benzo[3,4]azepino[1,2-a]indolacyclododecaphane-2,12-dione 4,4-dioxide; 13-Cyclohexyl-3-methoxy-17,23-dimethyl-7H-10,6-(methanoiminothioiminoethanooxyethanoiminomethano)indolo[2,1-a][2]benzazepine-14,16,16,24-tetrone; 28-Cyclohexyl-22-methoxy-10,16-dimethyl-9,9-dioxo-13-oxa-9λ6-thia-1,8,10,16-tetrazapentacyclo[16.8.1.12,6.13,26.020,25]nonacosa-2,4,6(29),18,20(25),21,23,26(28)-octaene-7,17-dione; MTC647055
- 用途
- TMC647055 是一种有效的 HCV 复制的非核苷 NS5B 聚合酶抑制剂,具有较强的 HCV 结合活性,其 IC50 值为 82 nM,可用于丙型肝炎病毒 (HCV) 的研究。